中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2014年
26期
84-86
,共3页
卢宇%费小蔷%杨淑芳%徐邦奎%马咏梅%赵成媛%李湘怡
盧宇%費小薔%楊淑芳%徐邦奎%馬詠梅%趙成媛%李湘怡
로우%비소장%양숙방%서방규%마영매%조성원%리상이
血β-羟丁酸%尿酮%糖尿病酮症
血β-羥丁痠%尿酮%糖尿病酮癥
혈β-간정산%뇨동%당뇨병동증
Bloodβ-hydroxy butyric acid%Urine ketone%Diabetic ketosis
目的:探讨血β-羟丁酸和尿酮在糖尿病酮症(DK)诊断中的意义。方法在末梢血糖>13.9 mmol/L的糖尿病患者中,同步检测末梢血β-羟丁酸和尿酮。结果(1)在81例糖尿病血糖>13.9 mmol/L的患者中,DK的发生率为13.58%,糖尿病酮症酸中毒(DKA)的发生率为9.88%。(2)末梢血糖与末梢血β-羟丁酸呈正相关(r=0.330,P=0.003),与尿酮无相关性。(3)末梢血β-羟丁酸与尿酮呈正相关(r=0.516,P=0.000)。(4)在DK或DKA患者中,5.26%(1/19)的患者尿酮(-)或(+-),36.84%(7/19)的患者血β-羟丁酸<1 mmol/L。(5)当以尿酮为标准诊断DK时,末梢血β-羟丁酸的切点值为0.35 mmol/L。结论单用尿酮或血β-羟丁酸诊断酮症均可能发生漏诊,联合监测血β-羟丁酸和尿酮可以减少酮症的漏诊率。当血β-羟丁酸轻度升高(≥0.35 mmol/L)时可能已经存在尿酮症,此时应该检测尿酮以避免漏诊DK。
目的:探討血β-羥丁痠和尿酮在糖尿病酮癥(DK)診斷中的意義。方法在末梢血糖>13.9 mmol/L的糖尿病患者中,同步檢測末梢血β-羥丁痠和尿酮。結果(1)在81例糖尿病血糖>13.9 mmol/L的患者中,DK的髮生率為13.58%,糖尿病酮癥痠中毒(DKA)的髮生率為9.88%。(2)末梢血糖與末梢血β-羥丁痠呈正相關(r=0.330,P=0.003),與尿酮無相關性。(3)末梢血β-羥丁痠與尿酮呈正相關(r=0.516,P=0.000)。(4)在DK或DKA患者中,5.26%(1/19)的患者尿酮(-)或(+-),36.84%(7/19)的患者血β-羥丁痠<1 mmol/L。(5)噹以尿酮為標準診斷DK時,末梢血β-羥丁痠的切點值為0.35 mmol/L。結論單用尿酮或血β-羥丁痠診斷酮癥均可能髮生漏診,聯閤鑑測血β-羥丁痠和尿酮可以減少酮癥的漏診率。噹血β-羥丁痠輕度升高(≥0.35 mmol/L)時可能已經存在尿酮癥,此時應該檢測尿酮以避免漏診DK。
목적:탐토혈β-간정산화뇨동재당뇨병동증(DK)진단중적의의。방법재말소혈당>13.9 mmol/L적당뇨병환자중,동보검측말소혈β-간정산화뇨동。결과(1)재81례당뇨병혈당>13.9 mmol/L적환자중,DK적발생솔위13.58%,당뇨병동증산중독(DKA)적발생솔위9.88%。(2)말소혈당여말소혈β-간정산정정상관(r=0.330,P=0.003),여뇨동무상관성。(3)말소혈β-간정산여뇨동정정상관(r=0.516,P=0.000)。(4)재DK혹DKA환자중,5.26%(1/19)적환자뇨동(-)혹(+-),36.84%(7/19)적환자혈β-간정산<1 mmol/L。(5)당이뇨동위표준진단DK시,말소혈β-간정산적절점치위0.35 mmol/L。결론단용뇨동혹혈β-간정산진단동증균가능발생루진,연합감측혈β-간정산화뇨동가이감소동증적루진솔。당혈β-간정산경도승고(≥0.35 mmol/L)시가능이경존재뇨동증,차시응해검측뇨동이피면루진DK。
Objcetive To investigate the relationship between blood β-hydroxybutyric acid and urine ketone in the di-agnosis of diabetic ketosis (DK). Methods Peripheral blood β-hydroxybutyric acid and urine ketone were detected when the peripheral blood glucose was more than 13.9 mmol/L in patients with diabetes. Results (1) In 81 diabetes pa-tients with blood glucose more than 13.9 mmol/L, the incidence of DK was 13.58% and the incidence of diabetic ke-toacidosis (DKA) was 9.88%. (2) The peripheral blood glucose was positively correlated with β-hydroxybutyric acid (r=0.330, P=0.003), but it was not correlated with urine ketone. (3) The peripheral blood β-hydroxybutyric acid was posi-tively correlated with urine ketone (r=0.516, P=0.000). (4) In patients with DK or DKA, 5.26%(1/19) of those were with urine ketone(-) or (+-), whereas 36.84% (7/19) of those were with blood β-hydroxybutyric acid less than 1 mmol/L. (5) When urine ketone was used as the reference test for diagnosis of DK, the optimal value of blood β-hydroxybutyric acid was 0.35 mmol/L. Conclusion For missed diagnosis of DK may be happend if blood β-hydroxybutyric acid or urine ketone is used alone, the co-monitoring of blood β-hydroxybutyric acid and urine ketone can reduce the inci-dence of missed diagnosis of DK. The urine ketosis may have existed when the blood β-hydroxybutyric acid is slightly elevated (≥0.35 mmol/L). In the situation, the urine ketone should be tested in order to avoid missed diagnosis of DK.